Fagan Associates, Inc. Invitae Corp Transaction History

Fagan Associates, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$14.7 - $28.67 $1.4 Million - $2.73 Million	-95,300 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$24.31 - $33.6 $54,211 - $74,928	-2,230 Reduced 2.29%	95,300 $2.71 Million
Q2 2021 Aug 06, 2021	BUY	$26.09 - $40.4 $179,238 - $277,548	6,870 Added 7.58%	97,530 $3.29 Million
Q1 2021 May 06, 2021	SELL	$33.06 - $56.93 $45,622 - $78,563	-1,380 Reduced 1.5%	90,660 $3.46 Million
Q4 2020 Feb 08, 2021	SELL	$39.09 - $57.4 $1.23 Million - $1.81 Million	-31,590 Reduced 25.55%	92,040 $3.85 Million

Q3 2020 Nov 02, 2020	BUY	$28.43 - $44.67 $114,999 - $180,690	4,045 Added 3.38%	123,630 $5.36 Million
Q2 2020 Aug 05, 2020	BUY	$11.71 - $30.29 $1.4 Million - $3.62 Million	119,585 New	119,585 $3.62 Million

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Fagan Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Fagan Associates, Inc. with notifications on news.